Pfizer, Mylan Join to Develop Generic Business in Japan

Aug. 23, 2012
Japan is the second-largest pharmaceutical market in the world, behind the United States, and the sixth-largest generic retail prescription market worldwide, with sales of approximately $5.2 billion in 2011.

Pfizer (IW 500/17), the world's largest drug maker, and U.S. generic drugs specialist Mylan have teamed up to develop their generic businesses in Japan.

"Pfizer and Mylan will each continue to operate independent entities in Japan, but will collaborate on current and future generic products, sharing the costs and profits resulting from the collaboration," the companies said Wednesday.

Their collaboration will include a portfolio of more than 350 marketed products across a broad range of therapeutic categories, as well as more than 125 additional products in development.

Products included are expected to be sold under the Pfizer brand with joint labeling.

Japan is the second-largest pharmaceutical market in the world, behind the United States, and the sixth-largest generic retail prescription market worldwide, with sales of approximately $5.2 billion in 2011, according to IMS Healthcare data.

The companies noted the Japanese market's attractive growth prospects: an aging population, numerous looming drug patent expires and government measures aimed at cutting health-care costs, including a plan to boost generic use from 24% to 30% by year-end.

The financial terms of the exclusive, long-term collaboration were not disclosed.

Copyright Agence France-Presse, 2012

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!